US Stock MarketDetailed Quotes

SLNO Soleno Therapeutics

Watchlist
  • 49.3400
  • +0.3100+0.63%
Close Mar 14 16:00 ET
  • 50.3000
  • +0.9600+1.95%
Post 16:37 ET
2.26BMarket Cap-11.26P/E (TTM)

Soleno Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
376.93%184.43M
358.25%58.79M
747.51%79.34M
179.55%23.23M
182.42%23.07M
54.01%38.67M
106.52%12.83M
53.38%9.36M
34.84%8.31M
23.21%8.17M
Selling and administrative expenses
685.26%105.86M
801.04%37.3M
1,382.73%49.2M
243.61%10.89M
196.85%8.47M
36.95%13.48M
72.36%4.14M
42.28%3.32M
28.46%3.17M
7.98%2.85M
-General and administrative expense
685.26%105.86M
801.04%37.3M
1,382.73%49.2M
243.61%10.89M
196.85%8.47M
36.95%13.48M
72.36%4.14M
42.28%3.32M
28.46%3.17M
7.98%2.85M
Research and development costs
211.91%78.57M
147.28%21.49M
398.73%30.14M
140.07%12.34M
174.68%14.6M
65.01%25.19M
128.06%8.69M
60.25%6.04M
39.10%5.14M
33.30%5.32M
Operating profit
-376.93%-184.43M
-358.25%-58.79M
-747.51%-79.34M
-179.55%-23.23M
-182.42%-23.07M
-54.01%-38.67M
-106.52%-12.83M
-53.38%-9.36M
-34.84%-8.31M
-23.21%-8.17M
Net non-operating interest income expense
358.53%11.82M
46.18%3.13M
1,966.67%3.6M
1,950.34%3.01M
1,738.05%2.08M
759.33%2.58M
1,615.20%2.14M
72.28%174K
182.69%147K
413.64%113K
Non-operating interest income
367.49%12.05M
56.95%3.37M
1,966.67%3.6M
1,950.34%3.01M
1,738.05%2.08M
759.33%2.58M
1,615.20%2.14M
72.28%174K
182.69%147K
413.64%113K
Non-operating interest expense
--231K
----
----
----
----
--0
----
----
----
----
Other net income (expense)
-11.95%-3.24M
46.48%-327K
47.61%-877K
-424.68%-1.64M
-34.11%-401K
-490.30%-2.9M
-201.66%-611K
-1,187.69%-1.67M
49.19%-312K
-133.79%-299K
Gain on sale of security
----
----
----
----
----
-706.67%-182K
47,100.00%470K
-32,750.00%-653K
-50.00%1K
----
Special income (charges)
-19.45%-3.24M
69.75%-327K
14.10%-877K
-423.00%-1.64M
-34.11%-401K
-481.18%-2.71M
-279.57%-1.08M
-673.48%-1.02M
49.19%-313K
-134.85%-299K
-Less：Restructuring and merger&acquisition
19.45%3.24M
-69.75%327K
-14.10%877K
423.00%1.64M
34.11%401K
481.18%2.71M
279.57%1.08M
673.48%1.02M
-49.19%313K
134.85%299K
Income before tax
-351.04%-175.85M
-395.59%-55.98M
-605.42%-76.62M
-157.86%-21.85M
-156.08%-21.4M
-62.00%-38.99M
-105.91%-11.3M
-77.12%-10.86M
-26.02%-8.48M
-45.98%-8.36M
Income tax
Net income
-351.04%-175.85M
-395.59%-55.98M
-605.42%-76.62M
-157.86%-21.85M
-156.08%-21.4M
-62.00%-38.99M
-105.91%-11.3M
-77.12%-10.86M
-26.02%-8.48M
-45.98%-8.36M
Net income continuous Operations
-351.04%-175.85M
-395.59%-55.98M
-605.42%-76.62M
-157.86%-21.85M
-156.08%-21.4M
-62.00%-38.99M
-105.91%-11.3M
-77.12%-10.86M
-26.02%-8.48M
-45.98%-8.36M
Minority interest income
Net income attributable to the parent company
-351.04%-175.85M
-395.59%-55.98M
-605.42%-76.62M
-157.86%-21.85M
-156.08%-21.4M
-62.00%-38.99M
-105.91%-11.3M
-77.12%-10.86M
-26.02%-8.48M
-45.98%-8.36M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-351.04%-175.85M
-395.59%-55.98M
-605.42%-76.62M
-157.86%-21.85M
-156.08%-21.4M
-62.00%-38.99M
-105.91%-11.3M
-77.12%-10.86M
-26.02%-8.48M
-45.98%-8.36M
Basic earnings per share
-85.59%-4.38
-256.16%-1.27
-92.63%-1.83
29.63%-0.57
32.95%-0.59
17.77%-2.36
38.52%-0.3566
-46.15%-0.95
-12.50%-0.81
17.76%-0.88
Diluted earnings per share
-85.59%-4.38
-256.16%-1.27
-92.63%-1.83
29.63%-0.57
32.95%-0.59
17.77%-2.36
38.52%-0.3566
-46.15%-0.95
-12.50%-0.81
17.76%-0.88
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 376.93%184.43M358.25%58.79M747.51%79.34M179.55%23.23M182.42%23.07M54.01%38.67M106.52%12.83M53.38%9.36M34.84%8.31M23.21%8.17M
Selling and administrative expenses 685.26%105.86M801.04%37.3M1,382.73%49.2M243.61%10.89M196.85%8.47M36.95%13.48M72.36%4.14M42.28%3.32M28.46%3.17M7.98%2.85M
-General and administrative expense 685.26%105.86M801.04%37.3M1,382.73%49.2M243.61%10.89M196.85%8.47M36.95%13.48M72.36%4.14M42.28%3.32M28.46%3.17M7.98%2.85M
Research and development costs 211.91%78.57M147.28%21.49M398.73%30.14M140.07%12.34M174.68%14.6M65.01%25.19M128.06%8.69M60.25%6.04M39.10%5.14M33.30%5.32M
Operating profit -376.93%-184.43M-358.25%-58.79M-747.51%-79.34M-179.55%-23.23M-182.42%-23.07M-54.01%-38.67M-106.52%-12.83M-53.38%-9.36M-34.84%-8.31M-23.21%-8.17M
Net non-operating interest income expense 358.53%11.82M46.18%3.13M1,966.67%3.6M1,950.34%3.01M1,738.05%2.08M759.33%2.58M1,615.20%2.14M72.28%174K182.69%147K413.64%113K
Non-operating interest income 367.49%12.05M56.95%3.37M1,966.67%3.6M1,950.34%3.01M1,738.05%2.08M759.33%2.58M1,615.20%2.14M72.28%174K182.69%147K413.64%113K
Non-operating interest expense --231K------------------0----------------
Other net income (expense) -11.95%-3.24M46.48%-327K47.61%-877K-424.68%-1.64M-34.11%-401K-490.30%-2.9M-201.66%-611K-1,187.69%-1.67M49.19%-312K-133.79%-299K
Gain on sale of security ---------------------706.67%-182K47,100.00%470K-32,750.00%-653K-50.00%1K----
Special income (charges) -19.45%-3.24M69.75%-327K14.10%-877K-423.00%-1.64M-34.11%-401K-481.18%-2.71M-279.57%-1.08M-673.48%-1.02M49.19%-313K-134.85%-299K
-Less：Restructuring and merger&acquisition 19.45%3.24M-69.75%327K-14.10%877K423.00%1.64M34.11%401K481.18%2.71M279.57%1.08M673.48%1.02M-49.19%313K134.85%299K
Income before tax -351.04%-175.85M-395.59%-55.98M-605.42%-76.62M-157.86%-21.85M-156.08%-21.4M-62.00%-38.99M-105.91%-11.3M-77.12%-10.86M-26.02%-8.48M-45.98%-8.36M
Income tax
Net income -351.04%-175.85M-395.59%-55.98M-605.42%-76.62M-157.86%-21.85M-156.08%-21.4M-62.00%-38.99M-105.91%-11.3M-77.12%-10.86M-26.02%-8.48M-45.98%-8.36M
Net income continuous Operations -351.04%-175.85M-395.59%-55.98M-605.42%-76.62M-157.86%-21.85M-156.08%-21.4M-62.00%-38.99M-105.91%-11.3M-77.12%-10.86M-26.02%-8.48M-45.98%-8.36M
Minority interest income
Net income attributable to the parent company -351.04%-175.85M-395.59%-55.98M-605.42%-76.62M-157.86%-21.85M-156.08%-21.4M-62.00%-38.99M-105.91%-11.3M-77.12%-10.86M-26.02%-8.48M-45.98%-8.36M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -351.04%-175.85M-395.59%-55.98M-605.42%-76.62M-157.86%-21.85M-156.08%-21.4M-62.00%-38.99M-105.91%-11.3M-77.12%-10.86M-26.02%-8.48M-45.98%-8.36M
Basic earnings per share -85.59%-4.38-256.16%-1.27-92.63%-1.8329.63%-0.5732.95%-0.5917.77%-2.3638.52%-0.3566-46.15%-0.95-12.50%-0.8117.76%-0.88
Diluted earnings per share -85.59%-4.38-256.16%-1.27-92.63%-1.8329.63%-0.5732.95%-0.5917.77%-2.3638.52%-0.3566-46.15%-0.95-12.50%-0.8117.76%-0.88
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Trending Stocks

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Strategy
MSTR
297.490
MARA Holdings
MARA
13.180
Petroleo Brasileiro SA Petrobras
PBR
13.430
4
Adobe
ADBE
394.740
5
Vale SA
VALE
9.810
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.